We’re proud to introduce the multidisciplinary team behind MAESTRO Health Innovators, selected as a Phase 1 winner of the HHS/NIH TOPx Tech Sprint for AI and Invisible Illness and advancing to Phase 2. @HHSGov
Bringing together experts in clinical research, vascular biology, and artificial intelligence, the team is working to better understand how biological differences across patients with complex chronic disorders may inform more targeted approaches to testing and treatment.
Meet the team:
- Dr. Michal Tal, PhD @ImmunoFever
- Paige Hansen Colburn @MIT_TRG
- Amy Rochlin @amyrochlin
- Tyler Myers, PhD - @tylerdmyers
- Nasa Sinnott-Armstrong, PhD @technopolymath
- Mady Hornig, MA, MD @Madyhor
- Tomer Tal, PhD @TomerTalVH
This collaboration reflects CODA’s commitment to bringing together expertise across disciplines to accelerate research toward better answers and treatments for patients.
Visit the link in our bio to watch a video and learn more about MAESTRO Health Innovators’ research for the TOPx HHS Tech Sprint. https://t.co/txUjZxM39M
LymeX @Lyme_X Lyme Moonshot in action with @HHSGov TOPx for AI and Invisible Illness #OpenData
Making invisible illness visible with open data, AI, and American innovation 🫥🇺🇸💪
I can't wait for our @HHSGov#TOPx Tech Sprint for AI and Invisible Illness MVP today!!! Phase 2 has been very exciting. We're the MAESTRO Health Innovators demonstrating how we can MEASURE it to CURE it: AI Powered Clinical Innovation!
Meet the team behind MAESTRO Health Innovators!
Mady Hornig, Michal Caspi Tal, Nasa Sinnott-Armstrong, Amy Rochlin, Tyler Myers, Tomer Tal & Paige Hansen Colburn bring together expertise across biomedical research, complex disorders & Al.
Learn more: https://t.co/utLpBAqqZ2